https://www.selleckchem.com/pr....oducts/emd-1214063.h
nant patients receiving allogeneic HCT to ensure optimal exposure for achievement of high-level stable myeloid chimerism.Fanconi anemia (FA) cells are characterized by genomic instability, which places FA patients at risk for malignancies such as leukemia and oropharyngeal/urogenital cancers. The risk of development of leukemia is theoretically eliminated after hematopoietic cell transplantation (HCT). Mixed chimerism (MC) in FA patients might have a unique implication because the persistent existence of FA cells might give rise to
Like
Comment
Share
